MGMT Promoter Methylation and BRAF V600E Mutations Are Helpful Markers to Discriminate Pleomorphic Xanthoastrocytoma from Giant Cell Glioblastoma

• Laura-Nanna Lohkamp ,

  * E-mail: Laura-Nanna.Lohkamp@charite.de

  Affiliation Department of Neuropathology, Charité Universitätsmedizin Berlin, Germany

  ⨯
• Maren Schinz,

  Affiliation Department of Neuropathology, Charité Universitätsmedizin Berlin, Germany

  ⨯
• Claire Gehlhaar,

  Affiliation Department of Neuropathology, Charité Universitätsmedizin Berlin, Germany

  ⨯
• Katrin Guse,

  Affiliation Department of Neuropathology, Charité Universitätsmedizin Berlin, Germany

  ⨯
• Ulrich-Wilhelm Thomale,

  Affiliation Department of Neurosurgery and Pediatric Neurosurgery, Charité Universitätsmedizin Berlin, Germany

  ⨯
• Peter Vajkoczy,

  Affiliation Department of Neurosurgery and Pediatric Neurosurgery, Charité Universitätsmedizin Berlin, Germany

  ⨯
• Frank L. Heppner,

  Affiliation Department of Neuropathology, Charité Universitätsmedizin Berlin, Germany

  ⨯
• Arend Koch

  Affiliation Department of Neuropathology, Charité Universitätsmedizin Berlin, Germany

  ⨯